Pharmaceuticals
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Trend Stats
1-Month Return
+1.49%
3-Month Return
-3.37%
12-Month Return
+22.33%
Volatility Score
1.6
RSI
41.5
ST Trend
Down
LT Trend
Up
Short-Term Trend
Down
The Short-Term Trend is a metric that gauges an ETF's short-term price trend.
Long-Term Trend
Up
The Long-Term Trend is a metric that gauges an ETF's long-term price trend.
Performance
Pharmaceuticals
S&P 500 Index
Components
| Symbol | Company | Market Cap | 12 mo return Performance over the past 12 months | 3 mo return Performance over the past 3 months | 1 mo return Performance over the past month | Vol Score Our gauge of the ETF's recent volatility | ST Trend A metric that gauges an ETF's short-term price trend | LT Trend A metric that gauges an ETF's long-term price trend |
|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly & Co | $807B | +9.93% | -16.13% | -0.41% | 3.0 | Down | Down |
| JNJ | Johnson&Johnson | $545B | +47.36% | +4.29% | -3.91% | 2.0 | Down | Up |
| ABBV | AbbVie | $363B | +21.88% | -4.32% | +0.85% | 2.5 | Down | Down |
| NVS | Novartis Sp ADR | $282B | +36.83% | +5.05% | +1.33% | 1.8 | Down | Up |
| MRK | Merck | $278B | +47.71% | +2.06% | -1.42% | 2.7 | Down | Up |
| NVO | Nordisk Sp ADR-B | $175B | -31.13% | -31.22% | +11.68% | 2.7 | Neutral | Down |
| PFE | Pfizer | $155B | +30.01% | +7.25% | +1.26% | 2.0 | Neutral | Up |
| BMY | Bristol-MyersSqu | $121B | +25.17% | +10.10% | +4.39% | 2.4 | Neutral | Up |
| SNY | SANOFI SP ADR | $113B | -5.11% | +2.06% | +5.67% | 1.8 | Neutral | Down |
| GSK | GSK Sp ADR | $112B | +59.39% | +17.67% | +8.26% | 2.1 | Down | Up |
| MCK | Mckesson | $103B | +21.64% | +2.39% | -4.92% | 2.2 | Down | Up |
| COR | Cencora | $61B | +9.91% | -11.04% | -4.44% | 2.6 | Down | Down |
| TAK | TAKEDA PHARM SP ADR | $54B | +13.79% | +6.09% | -4.32% | 2.0 | Down | Up |
| ZTS | Zoetis-A | $50B | -19.98% | -5.11% | +2.61% | 2.6 | Down | Down |
| HLN | Haleon Sp ADR | $42B | -5.89% | -5.70% | -4.11% | 1.6 | Down | Down |
| TEVA | TEVAPHARMIND SP ADR | $36B | +123.50% | -0.38% | +8.91% | 3.1 | Down | Up |
| VTRS | Viatris | $17B | +100.48% | +13.84% | +11.59% | 2.6 | Neutral | Up |
| JAZZ | Jazz Pharmaceuti | $12B | +92.52% | +17.66% | +10.19% | 2.5 | Up | Up |
| ELAN | ELANC ANIML HLTH | $11B | +154.33% | -6.95% | -5.71% | 4.5 | Down | Up |
| AXSM | Axsome Therapeut | $9.4B | +76.24% | -3.24% | +16.60% | 3.4 | Up | Up |
| MIDD | Middleby Corp | $6.6B | +11.86% | -5.15% | +4.96% | 3.5 | Down | Neutral |
| CORT | Corcept Therapeu | $4.8B | -30.27% | +24.21% | +30.20% | 5.5 | Up | Down |
| OGN | Organon | $2.3B | -20.59% | -7.59% | +46.60% | 6.5 | Up | Up |
| BHC-T | BAUSCH HEALTH | $0 | +9.05% | -14.98% | +13.48% | 3.2 | Neutral | Down |
| 0 | 0 | 0 | 0 | Bullish | Bullish |
